Maven Securities LTD Biogen Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $380,406 - $457,909	1,709 New	1,709 $442,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $1.62 Million - $2.04 Million	-8,350 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.87 Million - $2.4 Million	8,350 New	8,350 $2 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $905,205 - $1.45 Million	-3,495 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $630,941 - $739,184	2,597 Added 289.2%	3,495 $968,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $212,161 - $319,355	898 New	898 $220,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.